Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
54
2026
167
9.460
 Why?
Cystectomy
32
2025
52
6.040
 Why?
Prostatic Neoplasms
43
2024
401
4.720
 Why?
Kidney Neoplasms
22
2018
181
2.560
 Why?
Carcinoma, Transitional Cell
13
2023
54
2.480
 Why?
Prostatectomy
22
2023
84
2.180
 Why?
Nephrectomy
19
2016
81
1.850
 Why?
Lymph Node Excision
7
2024
132
1.690
 Why?
Urinary Diversion
6
2021
43
1.510
 Why?
Prostate
14
2024
118
1.430
 Why?
Laparoscopy
13
2014
180
1.430
 Why?
Quality of Life
13
2025
902
1.380
 Why?
Aged
82
2025
10429
1.240
 Why?
Male
121
2025
27435
1.160
 Why?
Middle Aged
88
2025
13419
1.100
 Why?
Humans
151
2026
53230
1.100
 Why?
Neoadjuvant Therapy
12
2024
124
1.050
 Why?
Neoplasm Staging
26
2026
774
1.000
 Why?
BCG Vaccine
7
2024
16
0.900
 Why?
Robotics
8
2015
43
0.890
 Why?
Postoperative Complications
15
2021
1099
0.850
 Why?
Neoplasm Recurrence, Local
16
2025
647
0.840
 Why?
Retrospective Studies
52
2024
6819
0.840
 Why?
Carcinoma, Renal Cell
10
2016
112
0.840
 Why?
Penile Neoplasms
3
2024
45
0.810
 Why?
Ureter
3
2016
35
0.760
 Why?
Exercise Therapy
1
2023
105
0.750
 Why?
Exercise
2
2023
561
0.730
 Why?
Hernia
2
2020
6
0.710
 Why?
Treatment Outcome
31
2025
5595
0.670
 Why?
Intestine, Small
2
2020
114
0.660
 Why?
Medical Oncology
5
2026
97
0.650
 Why?
Physical Fitness
1
2020
56
0.640
 Why?
Herniorrhaphy
1
2020
33
0.630
 Why?
Aged, 80 and over
27
2025
3494
0.630
 Why?
Intestinal Obstruction
1
2020
38
0.630
 Why?
Patient Readmission
6
2021
251
0.610
 Why?
Neoplasm Invasiveness
15
2025
281
0.610
 Why?
Image-Guided Biopsy
6
2024
36
0.600
 Why?
Watchful Waiting
7
2019
29
0.590
 Why?
Biopsy
17
2023
600
0.570
 Why?
Ureteral Neoplasms
2
2018
11
0.560
 Why?
Female
60
2025
28782
0.540
 Why?
Organ Sparing Treatments
5
2025
58
0.520
 Why?
Testicular Neoplasms
4
2024
46
0.520
 Why?
Magnetic Resonance Imaging
10
2023
1583
0.510
 Why?
Urinary Bladder
7
2018
101
0.500
 Why?
Prospective Studies
18
2025
2411
0.500
 Why?
Convalescence
1
2016
6
0.500
 Why?
Carcinoma, Squamous Cell
4
2024
332
0.490
 Why?
Neoplasm Grading
14
2025
128
0.480
 Why?
Neoplasms, Germ Cell and Embryonal
3
2024
21
0.470
 Why?
Urothelium
4
2018
20
0.450
 Why?
Carcinoma in Situ
4
2024
72
0.450
 Why?
Chemotherapy, Adjuvant
8
2024
122
0.440
 Why?
Ileum
1
2014
88
0.430
 Why?
Urologic Neoplasms
3
2019
12
0.430
 Why?
Choline
3
2019
64
0.420
 Why?
Quality Indicators, Health Care
1
2013
92
0.370
 Why?
Needles
3
2021
25
0.370
 Why?
Administration, Intravesical
7
2024
16
0.360
 Why?
Urologic Surgical Procedures
3
2016
30
0.360
 Why?
Disease Progression
8
2024
880
0.360
 Why?
Lymphatic Metastasis
4
2024
211
0.360
 Why?
Antineoplastic Agents
3
2021
1232
0.350
 Why?
Biopsy, Needle
5
2021
181
0.340
 Why?
Survival Rate
9
2021
949
0.340
 Why?
Prostate-Specific Antigen
8
2021
43
0.340
 Why?
Testicular Diseases
1
2011
9
0.340
 Why?
Risk Assessment
10
2019
1368
0.330
 Why?
Tumor Burden
6
2016
132
0.330
 Why?
Urogenital Neoplasms
1
2010
9
0.330
 Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.320
 Why?
Muscle Neoplasms
1
2010
17
0.320
 Why?
Registries
4
2023
652
0.310
 Why?
Fluorine Radioisotopes
2
2019
25
0.310
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1043
0.300
 Why?
Retroperitoneal Space
5
2016
26
0.300
 Why?
Recovery of Function
2
2023
203
0.300
 Why?
Psoas Muscles
2
2021
2
0.300
 Why?
Self Report
1
2010
225
0.300
 Why?
Adult
27
2024
14534
0.300
 Why?
Telomerase
2
2019
26
0.290
 Why?
Patient Selection
5
2019
273
0.280
 Why?
Urinary Incontinence
3
2023
40
0.270
 Why?
Deoxycytidine
3
2024
26
0.270
 Why?
Seat Belts
2
2017
17
0.270
 Why?
Child Restraint Systems
2
2017
18
0.270
 Why?
Urinary Catheterization
1
2007
24
0.270
 Why?
Positron-Emission Tomography
2
2019
298
0.260
 Why?
Urethral Stricture
1
2007
23
0.260
 Why?
Time Factors
13
2020
2991
0.260
 Why?
Rectum
2
2024
55
0.250
 Why?
Primary Health Care
1
2011
404
0.250
 Why?
Cohort Studies
8
2021
1557
0.250
 Why?
Tomography, X-Ray Computed
3
2021
1180
0.250
 Why?
Guideline Adherence
3
2017
143
0.250
 Why?
Length of Stay
6
2020
684
0.240
 Why?
Health Status
2
2015
306
0.240
 Why?
Patient Discharge
3
2017
325
0.240
 Why?
Pain Measurement
2
2017
259
0.240
 Why?
Kidney
4
2014
715
0.230
 Why?
Patient Participation
2
2016
72
0.230
 Why?
Carcinoma
2
2018
136
0.220
 Why?
Bandages
1
2005
28
0.220
 Why?
Adenoviridae
2
2024
46
0.220
 Why?
Surgical Wound Infection
1
2005
118
0.220
 Why?
Neurilemmoma
1
2004
25
0.220
 Why?
Age Factors
7
2021
1136
0.220
 Why?
Multivariate Analysis
8
2016
598
0.220
 Why?
Immunohistochemistry
5
2024
975
0.210
 Why?
Adenocarcinoma
3
2016
405
0.210
 Why?
Antimetabolites, Antineoplastic
1
2024
39
0.210
 Why?
Quality Improvement
3
2016
230
0.210
 Why?
Organoids
1
2024
41
0.210
 Why?
Venous Thrombosis
1
2005
91
0.210
 Why?
Follow-Up Studies
9
2024
2318
0.210
 Why?
Perineum
1
2024
26
0.210
 Why?
Antibiotic Prophylaxis
1
2024
65
0.200
 Why?
Decision Making
2
2016
278
0.200
 Why?
Clinical Competence
3
2016
406
0.200
 Why?
Practice Guidelines as Topic
2
2018
502
0.190
 Why?
Prognosis
9
2021
2118
0.190
 Why?
Urethra
3
2014
98
0.190
 Why?
Erectile Dysfunction
3
2023
94
0.180
 Why?
DNA, Neoplasm
2
2018
146
0.180
 Why?
United States
12
2020
5409
0.180
 Why?
Logistic Models
7
2021
947
0.180
 Why?
Feasibility Studies
2
2020
411
0.170
 Why?
Vital Statistics
1
2021
3
0.170
 Why?
Mandatory Reporting
1
2021
11
0.170
 Why?
DNA Mutational Analysis
3
2018
179
0.170
 Why?
Death Certificates
1
2021
17
0.170
 Why?
Birth Certificates
1
2021
26
0.170
 Why?
Cell Transdifferentiation
1
2021
8
0.170
 Why?
Cost-Benefit Analysis
2
2019
274
0.170
 Why?
Neuroendocrine Cells
1
2021
9
0.170
 Why?
Reproducibility of Results
7
2018
1219
0.170
 Why?
Urethral Diseases
2
2013
7
0.170
 Why?
Radiosurgery
1
2022
133
0.170
 Why?
Radiography, Abdominal
1
2020
25
0.160
 Why?
Mutation
5
2019
1337
0.160
 Why?
Reimbursement, Incentive
1
2020
12
0.160
 Why?
Genetic Vectors
1
2020
127
0.160
 Why?
Randomized Controlled Trials as Topic
4
2023
630
0.160
 Why?
Ablation Techniques
1
2019
19
0.150
 Why?
Genetic Therapy
1
2020
127
0.150
 Why?
Abdominal Pain
1
2020
84
0.150
 Why?
Diagnosis, Differential
2
2020
1038
0.150
 Why?
Venous Thromboembolism
1
2020
78
0.150
 Why?
Genetic Predisposition to Disease
5
2024
533
0.150
 Why?
Adjuvants, Immunologic
3
2024
52
0.150
 Why?
Urinary Tract
1
2018
24
0.150
 Why?
Lymphocytes
1
2019
146
0.150
 Why?
Predictive Value of Tests
6
2018
934
0.150
 Why?
Forecasting
1
2019
152
0.150
 Why?
Patient-Centered Care
1
2020
141
0.140
 Why?
Genetic Heterogeneity
1
2018
20
0.140
 Why?
RNA, Neoplasm
1
2018
45
0.140
 Why?
Obesity
2
2006
1204
0.140
 Why?
Neutrophils
1
2019
153
0.140
 Why?
Internship and Residency
2
2021
439
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2018
46
0.140
 Why?
Retroperitoneal Neoplasms
1
2018
17
0.140
 Why?
Orchiectomy
1
2018
38
0.140
 Why?
Drug Resistance, Neoplasm
1
2020
350
0.140
 Why?
Transurethral Resection of Prostate
1
2018
10
0.140
 Why?
Pain, Postoperative
2
2016
169
0.140
 Why?
Body Size
1
2017
32
0.130
 Why?
Quality Assurance, Health Care
1
2018
146
0.130
 Why?
Physician-Patient Relations
2
2016
146
0.130
 Why?
Inguinal Canal
1
2017
11
0.130
 Why?
Urodynamics
2
2014
24
0.130
 Why?
Sarcosine
1
2017
3
0.130
 Why?
Amino Acid Transport Systems
1
2017
5
0.130
 Why?
Databases, Factual
2
2021
742
0.130
 Why?
Anticoagulants
1
2020
280
0.130
 Why?
Body Height
1
2017
68
0.130
 Why?
Safety
1
2017
78
0.130
 Why?
Guidelines as Topic
1
2017
111
0.130
 Why?
Carbon Radioisotopes
1
2017
55
0.130
 Why?
Electronic Health Records
1
2020
287
0.130
 Why?
Disease-Free Survival
5
2016
466
0.130
 Why?
Transcriptome
2
2018
367
0.130
 Why?
Replantation
1
2016
11
0.130
 Why?
Scrotum
2
2015
31
0.130
 Why?
Protons
1
2017
75
0.120
 Why?
Nomograms
1
2016
8
0.120
 Why?
Laparotomy
1
2016
37
0.120
 Why?
Natural Orifice Endoscopic Surgery
1
2016
6
0.120
 Why?
Research Report
1
2016
19
0.120
 Why?
Physicians
2
2016
242
0.120
 Why?
Kaplan-Meier Estimate
5
2017
487
0.120
 Why?
Urinary Retention
2
2007
7
0.120
 Why?
Patient Preference
1
2016
44
0.120
 Why?
Ureteral Obstruction
1
2016
62
0.120
 Why?
Checklist
1
2016
40
0.120
 Why?
Preoperative Period
3
2021
47
0.120
 Why?
Time-to-Treatment
1
2016
81
0.120
 Why?
Sensitivity and Specificity
5
2018
867
0.110
 Why?
Genital Neoplasms, Male
1
2015
3
0.110
 Why?
Paget Disease, Extramammary
1
2015
6
0.110
 Why?
Body Weight
1
2017
524
0.110
 Why?
Lymph Nodes
1
2017
252
0.110
 Why?
Social Networking
1
2015
19
0.110
 Why?
Radiopharmaceuticals
1
2016
198
0.110
 Why?
Feedback
1
2015
53
0.110
 Why?
Treatment Failure
2
2017
119
0.110
 Why?
Video Recording
1
2015
81
0.110
 Why?
Informed Consent
1
2015
94
0.110
 Why?
Peer Group
1
2015
63
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2015
78
0.110
 Why?
Papilloma, Inverted
1
2014
1
0.110
 Why?
Equipment Design
3
2021
290
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
69
0.110
 Why?
Blood Loss, Surgical
5
2016
66
0.100
 Why?
Computer Simulation
1
2015
290
0.100
 Why?
Matched-Pair Analysis
1
2013
11
0.100
 Why?
Urinary Incontinence, Stress
1
2014
32
0.100
 Why?
Kidney Diseases
1
2016
230
0.100
 Why?
Adenoma
1
2015
114
0.100
 Why?
Diffusion of Innovation
1
2013
47
0.100
 Why?
Carcinoma, Papillary
1
2014
50
0.100
 Why?
Body Mass Index
3
2020
717
0.100
 Why?
General Surgery
1
2015
108
0.100
 Why?
Technology Transfer
1
2013
2
0.100
 Why?
Mitomycin
1
2013
19
0.100
 Why?
Longitudinal Studies
2
2018
774
0.100
 Why?
Radiotherapy, Adjuvant
2
2018
65
0.100
 Why?
Accreditation
1
2013
63
0.100
 Why?
Peripheral Nerves
1
2013
43
0.100
 Why?
Severity of Illness Index
2
2014
1049
0.100
 Why?
Education, Medical, Continuing
1
2013
76
0.090
 Why?
Operating Rooms
1
2012
27
0.090
 Why?
Pathology, Clinical
1
2012
25
0.090
 Why?
Community Health Centers
1
2012
33
0.090
 Why?
Referral and Consultation
2
2012
299
0.090
 Why?
Receptors, Androgen
2
2002
48
0.090
 Why?
Algorithms
1
2015
667
0.090
 Why?
Combined Modality Therapy
3
2021
640
0.090
 Why?
Neoplasms
1
2021
1334
0.080
 Why?
Perioperative Care
1
2011
44
0.080
 Why?
Risk Factors
5
2017
4017
0.080
 Why?
Seminal Vesicles
2
2022
13
0.080
 Why?
Skin Neoplasms
1
2015
500
0.080
 Why?
Phantoms, Imaging
2
2020
112
0.080
 Why?
Multicenter Studies as Topic
2
2023
114
0.080
 Why?
Medicare
3
2020
280
0.080
 Why?
Proportional Hazards Models
3
2016
445
0.070
 Why?
Markov Chains
2
2019
28
0.070
 Why?
Carboplatin
2
2022
57
0.070
 Why?
SEER Program
3
2014
106
0.070
 Why?
Immunotherapy
1
2010
266
0.070
 Why?
Postoperative Care
2
2020
109
0.070
 Why?
Healthcare Disparities
1
2011
312
0.070
 Why?
Ureteroscopy
1
2007
10
0.070
 Why?
Automobiles
2
2017
13
0.070
 Why?
Pandemics
2
2023
595
0.070
 Why?
Sarcopenia
2
2021
100
0.070
 Why?
Chi-Square Distribution
3
2013
291
0.070
 Why?
Incidence
2
2021
1085
0.070
 Why?
Diverticulum
1
2007
21
0.070
 Why?
Peritoneum
1
2007
16
0.070
 Why?
Cisplatin
2
2022
282
0.070
 Why?
Delphi Technique
2
2018
71
0.060
 Why?
Gene Amplification
2
2018
58
0.060
 Why?
Aftercare
2
2018
73
0.060
 Why?
Societies, Medical
2
2018
207
0.060
 Why?
Adrenalectomy
1
2006
31
0.060
 Why?
Gene Expression Profiling
2
2024
1112
0.060
 Why?
Promoter Regions, Genetic
2
2019
465
0.060
 Why?
Postoperative Hemorrhage
1
2006
54
0.060
 Why?
Case-Control Studies
3
2014
1212
0.060
 Why?
Fibrin Tissue Adhesive
1
2005
13
0.060
 Why?
Hand
1
2005
50
0.060
 Why?
Sex Factors
2
2020
747
0.060
 Why?
Tissue Adhesives
1
2005
15
0.060
 Why?
Genomics
2
2018
271
0.060
 Why?
Intestines
1
2006
159
0.060
 Why?
Suture Techniques
1
2005
57
0.060
 Why?
Renal Insufficiency
1
2005
108
0.060
 Why?
Diabetes Complications
1
2005
124
0.060
 Why?
Chromosomes, Human, Pair 12
1
2024
14
0.050
 Why?
Glomerular Filtration Rate
2
2016
128
0.050
 Why?
Drug Screening Assays, Antitumor
1
2024
136
0.050
 Why?
Superior Mesenteric Artery Syndrome
1
2004
3
0.050
 Why?
Mediastinal Neoplasms
1
2024
19
0.050
 Why?
Vulnerable Populations
1
2024
54
0.050
 Why?
Communication
2
2016
263
0.050
 Why?
Intraoperative Complications
1
2005
114
0.050
 Why?
Hernia, Inguinal
1
2004
22
0.050
 Why?
Phenotype
2
2018
803
0.050
 Why?
High-Throughput Nucleotide Sequencing
2
2015
180
0.050
 Why?
Cell Line, Tumor
2
2018
1470
0.050
 Why?
Neoplasms, Second Primary
1
2024
75
0.050
 Why?
Child
3
2024
7379
0.050
 Why?
Quality of Health Care
2
2015
189
0.050
 Why?
Ischemia
1
2004
158
0.050
 Why?
Perioperative Period
2
2013
21
0.050
 Why?
Papillomavirus Infections
2
2015
177
0.050
 Why?
Trinucleotide Repeats
1
2002
3
0.050
 Why?
Chromosome Aberrations
1
2024
297
0.050
 Why?
Liver Cirrhosis
1
2005
246
0.050
 Why?
Muscles
1
2022
110
0.050
 Why?
Odds Ratio
2
2014
567
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
65
0.050
 Why?
Smoking
1
2005
526
0.050
 Why?
Accidents, Traffic
2
2017
91
0.040
 Why?
Gallium Isotopes
1
2021
2
0.040
 Why?
Gallium Radioisotopes
1
2021
9
0.040
 Why?
Radiotherapy, Intensity-Modulated
2
2013
181
0.040
 Why?
Edetic Acid
1
2021
14
0.040
 Why?
Androgen Antagonists
1
2021
13
0.040
 Why?
Geography
1
2021
65
0.040
 Why?
Polymorphism, Single Nucleotide
1
2024
505
0.040
 Why?
Quarantine
1
2021
11
0.040
 Why?
Public Health
1
2023
231
0.040
 Why?
Internationality
1
2021
46
0.040
 Why?
Neoplasm Metastasis
2
2017
237
0.040
 Why?
Motion
1
2020
16
0.040
 Why?
Drug Dosage Calculations
1
2020
11
0.040
 Why?
Enoxaparin
1
2020
32
0.040
 Why?
Finite Element Analysis
1
2020
11
0.040
 Why?
Fellowships and Scholarships
1
2021
124
0.040
 Why?
Drug Monitoring
1
2020
81
0.040
 Why?
Pelvis
1
2020
66
0.040
 Why?
Abdomen
1
2020
71
0.040
 Why?
DNA-Directed RNA Polymerases
1
2019
11
0.040
 Why?
Heparin
1
2020
86
0.040
 Why?
Young Adult
2
2024
4511
0.040
 Why?
Postoperative Period
1
2020
169
0.040
 Why?
Social Behavior
1
2019
74
0.040
 Why?
Urine
1
2018
26
0.040
 Why?
Cytodiagnosis
1
2018
42
0.040
 Why?
Adolescent
2
2024
6907
0.040
 Why?
Diagnostic Errors
1
2018
68
0.040
 Why?
Single-Blind Method
1
2018
120
0.030
 Why?
Image Processing, Computer-Assisted
1
2019
235
0.030
 Why?
DNA Copy Number Variations
1
2018
117
0.030
 Why?
Genome, Human
1
2018
121
0.030
 Why?
Quality-Adjusted Life Years
1
2018
67
0.030
 Why?
Sequence Analysis, RNA
1
2018
96
0.030
 Why?
Random Allocation
1
2018
284
0.030
 Why?
Hospitalization
2
2017
749
0.030
 Why?
Delivery of Health Care, Integrated
1
2018
61
0.030
 Why?
Health Services Accessibility
2
2012
477
0.030
 Why?
Dose-Response Relationship, Drug
1
2020
1367
0.030
 Why?
Nephrons
1
2016
6
0.030
 Why?
Tissue Distribution
1
2017
174
0.030
 Why?
Hospital Communication Systems
1
2016
5
0.030
 Why?
Consensus
1
2018
206
0.030
 Why?
Coitus
1
2016
18
0.030
 Why?
Failure to Thrive
1
2016
19
0.030
 Why?
Anastomosis, Surgical
1
2016
69
0.030
 Why?
Salvage Therapy
1
2017
138
0.030
 Why?
Radiometry
1
2017
125
0.030
 Why?
Creatinine
1
2016
158
0.030
 Why?
Molecular Imaging
1
2016
28
0.030
 Why?
Early Detection of Cancer
1
2018
190
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
10
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
12
0.030
 Why?
Genes, erbB-1
1
2015
9
0.030
 Why?
Operative Time
1
2016
78
0.030
 Why?
Tape Recording
1
2015
7
0.030
 Why?
Fever
1
2016
112
0.030
 Why?
Socioeconomic Factors
2
2011
623
0.030
 Why?
Learning Curve
1
2015
20
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Oncology Service, Hospital
1
2014
14
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
48
0.030
 Why?
Vinblastine
1
2014
22
0.030
 Why?
Europe
1
2014
91
0.030
 Why?
Regression Analysis
1
2015
391
0.030
 Why?
North America
1
2014
75
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
In Situ Hybridization
1
2014
69
0.030
 Why?
Amino Acid Substitution
1
2014
79
0.030
 Why?
Personal Satisfaction
1
2014
76
0.030
 Why?
Kidney Failure, Chronic
1
2016
210
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
868
0.030
 Why?
Gene Dosage
1
2014
76
0.030
 Why?
Ultrasonography
1
2016
426
0.030
 Why?
Methotrexate
1
2014
78
0.030
 Why?
United States Department of Veterans Affairs
1
2015
295
0.030
 Why?
Papillomaviridae
1
2014
104
0.030
 Why?
Survivors
1
2014
120
0.030
 Why?
Anxiety
1
2016
321
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Anesthesiology
1
2014
37
0.030
 Why?
Cluster Analysis
1
2014
237
0.030
 Why?
Sequence Analysis, DNA
1
2014
216
0.030
 Why?
Intention to Treat Analysis
1
2013
30
0.020
 Why?
Prevalence
1
2016
1034
0.020
 Why?
Valsalva Maneuver
1
2013
10
0.020
 Why?
Stents
1
2016
376
0.020
 Why?
Diagnostic Tests, Routine
1
2013
31
0.020
 Why?
Health Services Research
1
2013
153
0.020
 Why?
Paclitaxel
1
2013
91
0.020
 Why?
Doxorubicin
1
2014
247
0.020
 Why?
Confidence Intervals
1
2013
158
0.020
 Why?
Neutropenia
1
2013
113
0.020
 Why?
Antibiotics, Antineoplastic
1
2013
83
0.020
 Why?
Survival Analysis
1
2014
659
0.020
 Why?
Thrombocytopenia
1
2013
89
0.020
 Why?
Angiomyolipoma
1
2012
9
0.020
 Why?
Attitude of Health Personnel
1
2015
371
0.020
 Why?
Unnecessary Procedures
1
2012
20
0.020
 Why?
Neoplasm, Residual
1
2013
171
0.020
 Why?
Tertiary Care Centers
1
2012
86
0.020
 Why?
Pilot Projects
1
2014
726
0.020
 Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
 Why?
Biopsy, Fine-Needle
1
2012
104
0.020
 Why?
Patient Positioning
1
2011
31
0.020
 Why?
Urination Disorders
1
2010
23
0.020
 Why?
Disease Management
1
2012
187
0.020
 Why?
Organ Size
1
2010
226
0.020
 Why?
Comorbidity
1
2012
638
0.020
 Why?
Health Status Disparities
1
2011
221
0.020
 Why?
Intraoperative Period
1
2007
46
0.020
 Why?
Erythrocyte Transfusion
1
2006
53
0.020
 Why?
Costs and Cost Analysis
1
2006
93
0.020
 Why?
Decision Trees
1
2005
23
0.010
 Why?
Portal System
1
2005
17
0.010
 Why?
Collateral Circulation
1
2005
39
0.010
 Why?
Hypertension, Portal
1
2005
23
0.010
 Why?
Reoperation
1
2006
476
0.010
 Why?
Blood Transfusion
1
2005
127
0.010
 Why?
Short Bowel Syndrome
1
2004
17
0.010
 Why?
Necrosis
1
2004
169
0.010
 Why?
Liver Transplantation
1
2005
174
0.010
 Why?
Polymorphism, Genetic
1
2002
181
0.010
 Why?
Genetic Markers
1
2002
104
0.010
 Why?
Statistics, Nonparametric
1
2002
198
0.010
 Why?
Base Sequence
1
2002
620
0.010
 Why?
Polymerase Chain Reaction
1
2002
452
0.010
 Why?
Molecular Sequence Data
1
2002
759
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department